Donor Milk vs. Formula in Extremely Low Birth Weight (ELBW) Infants
NCT01534481
Female Urogenital Diseases and Pregnancy Complications, Infant, Extremely Low Birth Weight
Birmingham, Alabama, United States
View Trial DetailsNCT Number: NCT01150071
Background: In a national Norwegian cohort of children born before 28 weeks gestation or with a birth weight less than 1000 g born in 1999 and 2000, 372 survived. Compared with earlier studies survival increased for the most immature infants, but at the cost of more early complications and a high rate of impairments, while the less immature children had fewer early complications and less impairments detectable within 5 years. These changes show the importance of monitoring outcome as treatment modalities change. Large brain haemorrhages were highly predictive of severe disabilities, but we have not found good predictive factors for milder impairments such as cognitive, behavioural and motor difficulties. However, at 5 years later function may be difficult to predict, and the children's potentials are better understood after completing several years in school. Objectives: The children will be re-examined at age 11 in order to assess their physical and mental health, and cognitive, motor and social function, and to determine if early life events and development at 2 and 5 years are predictive of long term health and functioning. MRI-studies, including functional MRI will be performed to examine if different outcomes related to brain function can be explained by differences in brain development. Methods: For all, data will be collected from the compulsory national test in 5th grade and questionnaires to the child, parents and teacher. For children in Western Norway (n=87) extensive examinations of lung and brain function, including clinical diagnostic tests and MRI, will be added. For all aspects of the study the investigators have appropriate current and historic reference populations for comparison. Implications: Knowledge on causes and of early predictions of outcome is needed to give appropriate advice to families, professionals and society, and to develop preventive programs.
Looking for future studies?
Notify Me10 year–12 year
All sexes
Observational
Haukeland University Hospital, Bergen, Norway
Questionnaires to parents: On general and neurosensory developmental Health (spesific questionnaire for the study) and pulmonary health (ISAAC-questionnaire). Mental Health and social functioning: Strengths and Difficulties (SDQ) questionnaire (also completed by Teachers), ASSQ and BRIEF.
Addtions for children born in the Western Norway Regional Health Authority:
All the children (n=52) and matched Controls born at term have measurements of height, weight and blood pressures, pulminary function tests, MRI and functional MRI of the brain, Assessment of bone mineralization and distribution of fat and muscle (DXA). Blood is collected in a biobank for assessment of inflammatory variables.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Eleven years old (years 2010, 2011)
Heigh and weight. In a subpopulation of 80 children: Also skin fold thicknesses and waist circumference
Time frame: Eleven years old (years 2010, 2011)
Questionnaires completed by parents (Strengths and Difficulties questionnaire, Parenting Stress Index,ASSQ)
Time frame: Eleven years old (years 2010, 2011)
Grades in 5th grade in school
Time frame: Eleven years of age (years 2010,2011)
Spirometry on a subgroup of 80 and 80 controls
Time frame: Eleven years of age (years 2010,2011)
fMRI on a subgroup of 40 and 40 controls
Time frame: Eleven years of age (years 2010,2011)
DXA measurements on a subgroup of 80 and 80 controls
University of Bergen
Other
Acronym: PEP11
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01534481
Female Urogenital Diseases and Pregnancy Complications, Infant, Extremely Low Birth Weight
Birmingham, Alabama, United States
View Trial DetailsNCT02696343
Behavior, Behavior, Animal
Los Angeles, California, United States
View Trial DetailsNCT01702805
Anemia, Bronchopulmonary Dysplasia
Birmingham, Alabama, United States
View Trial DetailsNCT05322980
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Azumino, Nagano, Japan
View Trial Details